We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




AI Identifies Non-Smokers at High Risk for Lung Cancer from Single Chest X-Ray

By HospiMedica International staff writers
Posted on 08 Dec 2023

Lung cancer is currently the leading cause of cancer mortality. More...

Notably, 10-20% of lung cancer cases are diagnosed in individuals classified as "never-smokers" – those who have either never smoked or have smoked fewer than 100 cigarettes in their lifetime. The prevalence of lung cancer in never-smokers is increasing, and these cases are often more advanced at the time of discovery due to the lack of early detection methods typically used for smokers. Now, a new study has found that an artificial intelligence (AI) tool is capable of identifying non-smokers at high risk for lung cancer by analyzing routine chest X-ray images.

Conducted by the Massachusetts General Hospital (MGH, Boston, MA, USA), this study aimed to enhance the prediction of lung cancer risk in never-smokers. The research team employed a deep learning model, a sophisticated form of AI, to analyze chest X-ray images from the electronic medical record, searching for patterns indicative of disease. The deep learning model, named "CXR-Lung-Risk," was trained using 147,497 chest X-rays from 40,643 asymptomatic individuals, both smokers and never-smokers. This model was designed to assess lung-related mortality risk from a single chest X-ray.

The effectiveness of the model was then tested on a separate cohort of never-smokers who underwent routine outpatient chest X-rays between 2013 and 2014. The primary measure was the incidence of lung cancer within six years, identified via International Classification of Disease codes. The model categorized the risk scores into low, moderate, and high-risk groups based on predetermined risk thresholds. In the study group of 17,407 patients, averaging 63 years of age, the model classified 28% as high risk, and within this group, 2.9% later had a diagnosis of lung cancer. The high-risk group surpassed the 1.3% six-year risk threshold where lung cancer screening CT is recommended by the US National Comprehensive Cancer Network guidelines. After taking into account age, sex, race, previous lower respiratory tract infection, and prevalent chronic obstructive pulmonary disease, the high-risk group still had a 2.1 times greater risk of developing lung cancer than the low-risk group.

"This AI tool opens the door for opportunistic screening for never-smokers at high risk of lung cancer, using existing chest X-rays in the electronic medical record," said senior author Michael T. Lu, M.D., M.P.H., director of artificial intelligence and co-director of CIRC at MGH. "Since cigarette smoking rates are declining, approaches to detect lung cancer early in those who do not smoke are going to be increasingly important."

Related Links:
MGH


Gold Member
Blood Gas Analyzer
i-Check200
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Medical Adhesive
MED 5570U
Surgical Dressing
ALLEVYN Ag+ SURGICAL
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Artificial Intelligence

view channel
Image: Artificial intelligence (AI) standalone performance and reader performance with versus without AI assistance. (A) Receiver operating characteristics (ROC) curve for AI standalone performance in the US dataset (AUC 0.899, 95% CI 0.858 to 0.939). (B) ROC curve for AI standalone performance in the Korean dataset (AUC 0.963, 95% CI 0.946 to 0.975). (C) Pooled reader ROC without (AUC 0.718) versus with (AUC 0.852) AI assistance in the Korean dataset; P<0.001. AUC, area under the receiver operating characteristics curve. (Leonard Sunwoo et al., Journal of NeuroInterventional Surgery (2026). DOI: 10.1136/jnis-2026-025339)

AI Improves Non-Contrast CT Interpretation for Time-Sensitive Stroke Assessment

Acute ischemic stroke occurs when a blood vessel in the brain becomes blocked, requiring rapid diagnosis to enable timely reperfusion therapy. Emergency departments often use computed tomography angiography... Read more

Surgical Techniques

view channel
Image: Researchers developed a handheld photothermal mid-infrared spectroscopic imaging (MIRSI) system that measures just 8 square inches. Probe light from a visible (red) diode laser and pump light from a modulated quantum cascade laser (QCL) are coupled into optical fibers and delivered to a flexible, handheld imager (blue dashed box). The beams are combined at a short-pass dichroic mirror and focused onto the sample using an off-axis parabolic mirror (OAP). (Image Credit:Rohith Reddy, University of Houston)

Handheld Infrared Imaging Device Supports Tumor Margin Assessment During Surgery

Accurately determining tumor margins during surgery remains challenging. Frozen-section pathology takes time and can miss residual disease, potentially leading to repeat surgery and delayed therapy.... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: LigaSure RAS Maryland, designed for the Valleylab FT10 platform on Hugo RAS, seals and cuts vessels, tissue, and lymphatics up to 7 mm in diameter (Photo courtesy of Medtronic)

Medtronic Receives FDA Clearance for Vessel-Sealing Instrument for Robotic Surgery

As robotic-assisted surgery expands across U.S. hospitals, teams increasingly seek energy instruments with the familiarity and performance of tools used in open and laparoscopic procedures.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.